Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.
暂无分享,去创建一个
S. Bione | D. Toniolo | J. Peluso | O. Hovatta | M. Wehling | N. Dahl | I. Golovleva | J. Schuster | E. Stattin | B. Carlsson | J. Badhai | R. Lösel | M. Mansouri | P. Karlström | Eva-Lena Stattin
[1] A. Shelling. Premature ovarian failure. , 2010, Reproduction.
[2] A. Rajkovic,et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. , 2008, American journal of human genetics.
[3] J. Peluso,et al. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. , 2008, Endocrinology.
[4] A. Rajkovic,et al. NOBOX homeobox mutation causes premature ovarian failure. , 2007, American journal of human genetics.
[5] M. Cahill. Progesterone receptor membrane component 1: An integrative review , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[6] M. Bard,et al. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. , 2007, Cell metabolism.
[7] J. Peluso,et al. Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. , 2006, The Journal of clinical endocrinology and metabolism.
[8] M. Skinner,et al. Interactions between progesterone and tumor necrosis factor-alpha in the regulation of primordial follicle assembly. , 2006, Reproduction.
[9] J. Peluso,et al. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. , 2006, Endocrinology.
[10] S. Bione,et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. , 2006, Human reproduction.
[11] R. A. Goldbeck,et al. Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1p. , 2005, Biochemistry.
[12] G. Vinson,et al. Molecular identification of adrenal inner zone antigen as a heme‐binding protein , 2005, The FEBS journal.
[13] Peter Gustavsson,et al. Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation , 2005, European Journal of Human Genetics.
[14] D. Kleinjan,et al. Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.
[15] J. Peluso,et al. Progesterone Regulates Granulosa Cell Viability Through a Protein Kinase G-Dependent Mechanism That May Involve 14-3-3σ1 , 2004, Biology of reproduction.
[16] P. Beck‐Peccoz,et al. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. , 2004, American journal of human genetics.
[17] J. Peluso,et al. Involvement of an unnamed protein, RDA288, in the mechanism through which progesterone mediates its antiapoptotic action in spontaneously immortalized granulosa cells. , 2004, Endocrinology.
[18] N. Horike,et al. Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis , 2004, Molecular and Cellular Endocrinology.
[19] E. Jabs,et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome , 2004, Nature Genetics.
[20] R. Laxová,et al. The critical region on the human Xq , 1990, Human Genetics.
[21] D. Russell. The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.
[22] R. Schiffmann,et al. Ovarian failure related to eukaryotic initiation factor 2B mutations. , 2003, American journal of human genetics.
[23] G. Schotta,et al. Position-effect variegation and the genetic dissection of chromatin regulation in Drosophila. , 2003, Seminars in cell & developmental biology.
[24] C. Gillberg,et al. A candidate region for Asperger syndrome defined by two 17p breakpoints , 2003, European Journal of Human Genetics.
[25] M. Sowers,et al. Premature menopause in a multi-ethnic population study of the menopause transition. , 2003, Human reproduction.
[26] A. Bateman,et al. Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain , 2002, Genome Biology.
[27] W. Umek,et al. Genetic disorders in premature ovarian failure. , 2002, Human reproduction update.
[28] D. Schlessinger,et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome , 2001, Nature Genetics.
[29] Ann E. Taylor,et al. Systemic Adversities of Ovarian Failure , 2001, Journal of the Society for Gynecologic Investigation.
[30] A. Zinn,et al. The X Chromosome and the Ovary , 2001, Journal of the Society for Gynecologic Investigation.
[31] A. Shelling,et al. Inhibin: a candidate gene for premature ovarian failure. , 2000, Human reproduction.
[32] A. Murray,et al. Microdeletions in FMR2 may be a significant cause of premature ovarian failure , 1999, Journal of medical genetics.
[33] W. Brown,et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.
[34] S. Shalet,et al. Gonadal damage from chemotherapy and radiotherapy. , 1998, Endocrinology and metabolism clinics of North America.
[35] E. Falkenstein,et al. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. , 1996, Biochemical and biophysical research communications.
[36] C. Tsigos,et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. , 1996, The New England journal of medicine.
[37] C. Tsigos,et al. Testicular and Ovarian Resistance to Luteinizing Hormone Caused by Inactivating Mutations of the Luteinizing Hormone–Receptor Gene , 1996 .
[38] G. Kaltsas,et al. Characterization of idiopathic premature ovarian failure , 1996, Fertility and sterility.
[39] A. Chapelle,et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure , 1995, Cell.
[40] H. Zoghbi,et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.
[41] G. Vinson,et al. Monoclonal antibodies against rat adrenocortical cell antigens. , 1988, Acta endocrinologica.
[42] J. Annegers,et al. Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.